Biosimilars for Cancer Treatment : A Promising Approach |
Autore | Bhatt Shvetank |
Edizione | [1st ed.] |
Pubbl/distr/stampa | Singapore : , : Springer, , 2024 |
Descrizione fisica | 1 online resource (316 pages) |
Altri autori (Persone) |
DurejaHarish
Gunvantbhai PatelSamir Samir PatelArchita DuaKamal |
ISBN | 981-9730-01-5 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910869176203321 |
Bhatt Shvetank | ||
Singapore : , : Springer, , 2024 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Immunotherapy Against Lung Cancer [[electronic resource] ] : Emerging Opportunities and Challenges / / edited by Shvetank Bhatt, Rajaraman Eri Eri, Bey-Hing Goh, Keshav Raj Paudel, Terezinha de Jesus Andreoli Pinto, Kamal Dua |
Autore | Bhatt Shvetank |
Edizione | [1st ed. 2023.] |
Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2023 |
Descrizione fisica | 1 online resource (393 pages) |
Disciplina | 616.994 |
Altri autori (Persone) |
EriRajaraman Eri
GohBey-Hing PaudelKeshav Raj Andreoli PintoTerezinha de Jesus DuaKamal |
Soggetto topico |
Cancer - Treatment
Tumors - Immunological aspects Cancer Therapy Tumour Immunology |
ISBN | 981-9971-41-1 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Chapter 1_An introduction to Lung cancer -- Chapter 2_Immunobiology of Lung cancer -- Chapter 3_Evolution of Lung cancer treatment from classical chemotherapy to advanced immunotherapy -- Chapter 4_Recent advances in the immunotherapy of Lung cancer -- Chapter 5_PD-1/PD-L1 inhibitors for the treatment of Lung cancer -- Chapter 6_CTLA-4 inhibitors for the treatment of Lung cancer -- Chapter 7_Adoptive T cell therapy for the treatment of Lung cancer -- Chapter 8_LAG-3 inhibitors for the treatment of Lung cancer -- Chapter 9_IDO and TGF-β inhibitors for the treatment of Lung cancer -- Chapter 10_OX40 and CD40 agonists for the treatment of Lung cancer -- Chapter 11_ICOS and GITR agonists for the treatment of Lung cancer -- Chapter 12_Vaccines and oncolytic virus for the treatment of Lung cancer.-Chapter 13_Targeting Toll-like receptors for the treatment of Lung cancer -- Chapter 14_Current and future perspectives of combining chemotherapy and stereotactic body radiation therapy with immunotherapy -- Chapter 15_Synergistic potential of PD-1/PD-L1 inhibitors and CTLA-4 inhibitors for the treatment of Lung cancer -- Chapter 16_Synergistic potential of antigen-specific vaccines and immunomodulatory agents for the treatment of Lung cancer -- Chapter 17_Important biomarkers for better evaluation of checkpoint inhibitors and another immunotherapy in Lung cancer -- Chapter 18_Insight on the clinical trials of immunotherapy for the treatment of Lung cancer -- Chapter 19_Future perspectives of the Cancer Immunotherapy for the treatment of Lung cancer. |
Record Nr. | UNINA-9910845494503321 |
Bhatt Shvetank | ||
Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2023 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Immunotherapy Against Lung Cancer [[electronic resource] ] : Emerging Opportunities and Challenges / / edited by Shvetank Bhatt, Rajaraman Eri Eri, Bey-Hing Goh, Keshav Raj Paudel, Terezinha de Jesus Andreoli Pinto, Kamal Dua |
Autore | Bhatt Shvetank |
Edizione | [1st ed. 2023.] |
Pubbl/distr/stampa | Springer Nature Singapore, 2023 |
Descrizione fisica | 1 online resource (393 pages) |
Disciplina | 616.994 |
Altri autori (Persone) |
EriRajaraman Eri
GohBey-Hing PaudelKeshav Raj Andreoli PintoTerezinha de Jesus DuaKamal |
Soggetto topico |
Cancer - Treatment
Tumors - Immunological aspects Cancer Therapy Tumour Immunology |
ISBN | 981-9971-41-1 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Chapter 1_An introduction to Lung cancer -- Chapter 2_Immunobiology of Lung cancer -- Chapter 3_Evolution of Lung cancer treatment from classical chemotherapy to advanced immunotherapy -- Chapter 4_Recent advances in the immunotherapy of Lung cancer -- Chapter 5_PD-1/PD-L1 inhibitors for the treatment of Lung cancer -- Chapter 6_CTLA-4 inhibitors for the treatment of Lung cancer -- Chapter 7_Adoptive T cell therapy for the treatment of Lung cancer -- Chapter 8_LAG-3 inhibitors for the treatment of Lung cancer -- Chapter 9_IDO and TGF-β inhibitors for the treatment of Lung cancer -- Chapter 10_OX40 and CD40 agonists for the treatment of Lung cancer -- Chapter 11_ICOS and GITR agonists for the treatment of Lung cancer -- Chapter 12_Vaccines and oncolytic virus for the treatment of Lung cancer.-Chapter 13_Targeting Toll-like receptors for the treatment of Lung cancer -- Chapter 14_Current and future perspectives of combining chemotherapy and stereotactic body radiation therapy with immunotherapy -- Chapter 15_Synergistic potential of PD-1/PD-L1 inhibitors and CTLA-4 inhibitors for the treatment of Lung cancer -- Chapter 16_Synergistic potential of antigen-specific vaccines and immunomodulatory agents for the treatment of Lung cancer -- Chapter 17_Important biomarkers for better evaluation of checkpoint inhibitors and another immunotherapy in Lung cancer -- Chapter 18_Insight on the clinical trials of immunotherapy for the treatment of Lung cancer -- Chapter 19_Future perspectives of the Cancer Immunotherapy for the treatment of Lung cancer. |
Record Nr. | UNINA-9910853990503321 |
Bhatt Shvetank | ||
Springer Nature Singapore, 2023 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|